Search Results - "Peachey, Lynnda"

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial by Dutton, Susan J, MSc, Ferry, David R, Prof, Blazeby, Jane M, Prof, Abbas, Haider, MRCP, Dahle-Smith, Asa, MBChB, Mansoor, Wasat, PhD, Thompson, Joyce, FRCP, Harrison, Mark, PhD, Chatterjee, Anirban, FRCR, Falk, Stephen, MD, Garcia-Alonso, Angel, MD, Fyfe, David W, MD, Hubner, Richard A, PhD, Gamble, Tina, Peachey, Lynnda, BSc, Davoudianfar, Mina, BA, Pearson, Sarah R, BSc, Julier, Patrick, MSc, Jankowski, Janusz, Prof, Kerr, Rachel, MD, Petty, Russell D, MRCP

“…Summary Background Evidence is scarce for the effectiveness of therapies for oesophageal cancer progressing after chemotherapy, and no randomised trials have…”
Get full text

Patient-reported outcomes from a phase III multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy: Cancer Oesophagus Gefitinib (COG) by Dutton, Susan J., Blazeby, Jane M., Petty, Russell D., Mansoor, Wasat, Thompson, Joyce, Harrison, Mark, Abbas, Haider, Dahle-Smith, Asa, Chatterjee, Anirban, Falk, Stephen, Garcia-Alonso, Angel, Fyfe, David Walter, Hubner, Richard, Gamble, Tina, Peachey, Lynnda, Harvey, Christine, Julier, Patrick, Jankowski, Janusz, Midgley, Rachel, Ferry, David R.

“…Abstract only 6 Background: There are no randomised trials of 2 nd line chemotherapy for esophageal cancer. The phase III COG trial of gefitinib versus placebo…”
Get full text